MAPT and Alzheimer disease: Moreover, the PI3K/Akt signalling pathway can also inactivate glycogen synthase kinase 3 β (GSK3β), which, in turn, is unable to phosphorylate the Tau protein [150,151], thereby unfavouring the Tau aggregation characteristic of AD.